Prescient Therapeutics Limited Dividend 2022

Prescient Therapeutics Limited (PTX) is a clinical stage oncology company developing novel compounds that show potential new therapies to treat a range of cancers that have become resistant to front line chemotherapy. The company continues to develop its two drug candidates, PTX-100 and PTX-200, for potential new therapies to treat a range of cancers, including breast and ovarian cancer, as well as leukaemia.

Prescient Therapeutics Limited operators in Health Care sector and under industry of Biotechnology. The company website is:

You can also check out dividend history for similar stocks in the same sector as follows:

PTX Dividend Dates

Please click the table header to sort the data.

No Dividend Dates Found